69.52 +0.38 (0.55%)
NVO
Stock Details
Last Trade:69.52 Change:+0.38 (0.55%) Prev Close:69.14 Open: 68.84 Days Range:68.84 – 70.36 52 Week Range: 41.35 - 85.00 Volume:1013299 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/10
Recent Alert on 01/26/10 at 9:22am
Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN)
Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN)
In an opposing view to other analysts today, Canaccord Adams said FDA approval of Novo Nordisk's (NYSE: NVO) Victoza will have a negative impact on Amylin Pharmaceuticals (Nasdaq: AMLN) "This is the first direct competition to the Byetta... Read More
Recent Alert on 01/26/10 at 7:03am
Novo Nordisk (NVO) Announces FDA Approval of Victoza for Type 2 Diabetes
Novo Nordisk (NVO) Announces FDA Approval of Victoza for Type 2 Diabetes
Recent Alert on 12/08/09 at 7:18am
Novo Nordisk (NVO) to License ZymoGenetics (ZGEN) IL-21 Monoclonal Antibody
Novo Nordisk (NVO) to License ZymoGenetics (ZGEN) IL-21 Monoclonal Antibody
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/31/10 at 10:11am
China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.
China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.
Blog Posts on 01/26/10 at 11:50am
Analyst Upgrades, Downgrades and Initiations: AMLN, CI, CTXS, HSY, KRA, TSCO, TXN ...
Analyst Upgrades, Downgrades and Initiations: AMLN, CI, CTXS, HSY, KRA, TSCO, TXN ...